Moderna Inc (NASDAQ:MRNA)
| 218.85 Delayed Data As of Jun 11 |  +1.85 / +0.85%Today’s Change | 54.21 Today|||52-Week Range 227.71 | +109.49% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 217.00 |
| Today’s open | 211.88 |
| Day’s range | 211.88 - 218.90 |
| Volume | 244,818 |
| Average volume (3 months) | 9,566,457 |
| Market cap | $87.9B |
Data as of 4:18pm ET, 06/11/2021
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,390.65% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | 177.9 |
| Price/Sales | 49.59 |
| Price/Book | 34.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +2.58 | +0.57% |
| GILDGilead Sciences | -0.52 | -0.75% |
| BIIBBiogen | -18.45 | -4.45% |
| ---- |
Data as of 5:36pm ET, 06/11/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | $6.20 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
